Terms: = Bone cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Clinical Outcome
4 results:
1. Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21 - A comprehensive cytogenetic profiling of three cases with review of literature.
Akhila Raj TV; Gopinath P; Geetha Raj JA; Narayanan G; Nair SG; Joy Philip DS; Raveendran S; Geetha P; Sreedharan H
J Cancer Res Ther; 2022; 18(3):697-703. PubMed ID: 35900542
[TBL] [Abstract] [Full Text] [Related]
2. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.
Zhao Y; Zhang T; Zhao Y; Zhou J
Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803
[TBL] [Abstract] [Full Text] [Related]
3. Pediatric acute myeloid leukemia with t(7;21)(p22;q22).
Paulraj P; Diamond S; Razzaqi F; Ozeran JD; Longhurst M; Andersen EF; Toydemir RM; Hong B
Genes Chromosomes Cancer; 2019 Aug; 58(8):551-557. PubMed ID: 30706625
[TBL] [Abstract] [Full Text] [Related]
4. Levels of the soluble, 55-kilodalton isoform of tumor necrosis factor receptor in bone marrow are correlated with the clinical outcome of children with acute lymphoblastic leukemia in first recurrence.
Wu S; Korte A; Gessner R; Henze G; Seeger K
Cancer; 2003 Aug; 98(3):625-31. PubMed ID: 12879482
[TBL] [Abstract] [Full Text] [Related]
